Tamoxifen’s Impact on Glycemic Control in American Males: A 12-Month Study
Reading Time: 2 minutes Introduction Tamoxifen, a widely used selective estrogen receptor modulator (SERM), is primarily prescribed for the treatment and prevention of hormone receptor-positive breast cancer. While its efficacy in cancer management is well-documented, the impact of tamoxifen on metabolic parameters, such as blood sugar levels, remains a subject of ongoing research. This article delves into a recent study that specifically examines the effects of tamoxifen on glycemic control in American males, providing valuable insights into its metabolic implications. Study Design and Methodology The study involved a cohort of 200 American males aged between 40 and 70 years, who were prescribed tamoxifen for...


